Prostaglandin E2 induces expression of receptor activator of nuclear factor-κB ligand/osteoprotegrin ligand on pre-B cells: Implications for accelerated osteoclastogenesis in estrogen deficiency

Journal of Bone and Mineral Research

Volumn 15, Issue 7, 2000, Pages 1321-1329

  Kanematsu, Masahiro ^a   Sato, Takuya ^a   Takai, Hiroyuki ^a   Watanabe, Ken ^a   Ikeda, Kyoji ^a   Yamada, Yoshiji ^a,b  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b GIFU INTERNATIONAL INSTITUTE OF BIOTECHNOLOGY   (Japan)

Author keywords

Estrogen deficiency; Osteoclastogenesis; Pre B cells; Prostaglandin E2; Receptor activator of nuclear factor B ligand

Indexed keywords

CYCLOOXYGENASE 2; INDOMETACIN; INTERLEUKIN 1; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; CARRIER PROTEIN; CYCLOHEXIMIDE; DACTINOMYCIN; ESTROGEN; MEMBRANE PROTEIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BONE ATROPHY; BONE MARROW CELL; CONTROLLED STUDY; ESTROGEN DEFICIENCY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC CELL; MOUSE; NONHUMAN; NORTHERN BLOTTING; OSTEOCLAST; OSTEOLYSIS; PRE B LYMPHOCYTE; PROTEIN EXPRESSION; ANIMAL; B LYMPHOCYTE; BIOLOGICAL MODEL; BONE DEVELOPMENT; CELL ADHESION; CELL LINE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; MOUSE STRAIN; OVARIECTOMY; PHYSIOLOGY; PROTEIN SYNTHESIS; STROMA CELL;

ANIMALS; B-LYMPHOCYTES; BONE MARROW CELLS; CARRIER PROTEINS; CELL ADHESION; CELL LINE; CYCLOHEXIMIDE; DACTINOMYCIN; DINOPROSTONE; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; INDOMETHACIN; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; MODELS, BIOLOGICAL; OSTEOCLASTS; OSTEOGENESIS; OVARIECTOMY; PROTEIN BIOSYNTHESIS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; STROMAL CELLS; TRANSCRIPTION, GENETIC;

EID: 0033623876     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2000.15.7.1321     Document Type: Article

References (33)

1. Manolagas SC, Jilka RL 1995 Bone marrow, cytokines, and bone remodeling: Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305-311.
2. Pacifici R 1996 Estrogen, cytokines, and pathogenesis of post-menopausal osteoporosis. J Bone Miner Res 11:1043-1051.
3. Masuzawa T, Miyaura C, Onoe Y, Kusano K, Ohta H, Nozawa S, Suda T 1994 Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J Clin Invest 94:1090-1097.
4. Miyaura C, Onoe Y, Inada M, Maki K, Ikuta K, Ito M, Suda T 1997 Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: Similarity to estrogen deficiency. Proc Natl Acad Sci U S A 94:9360-9365.
5. Lacey DL, Timms E, Tan H-L, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian Y-X, Kaufman S, Sarosi I, Shalhoub Y, Senaldi G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
6. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.
7. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang M-S, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan H-L, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Amgen EST Program, Boyle WJ 1997 Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
8. Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T, Higashio K 1997 Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 234:137-142.
9. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L 1997 A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175-179.
10. Wong BR, Josien R, Lee SY, Sauter B, Li H-L, Steinman RM, Choi Y 1997 TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 186:2075-2080.
11. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345-357.
12. Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, Morinaga T, Toyama Y, Yabe Y, Higashio K, Suda T 1998 Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Commun 246:199-204.
13. Quinn JMW, Elliott J, Gillespie MT, Martin TJ 1998 A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for human and mouse osteoclast formation in vitro. Endocrinology 139:4424-4427.
14. Burgess TL, Qian YX, Kaufman S, Ring BD, Van G, Capparelli C, Kelley M, Hsu H, Boyle WJ, Dunstan CR, Hu S, Lacey DL 1999 The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol 145:527-538.
15. Kong Y-Y, Yoshida H, Sarosi I, Tan H-L, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
16. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan H-L, Elliot G, Kelley MJ, Sarosi I, Wang L, Xia X-Z, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle W 1999 Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96:3540-3545.
17. Kawaguchi H, Pilbeam CC, Vargas SJ, Morse EE, Lorenzo JA, Raisz LG 1995 Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae. J Clin Invest 96:539-548.
18. Miyaura C, Kusano K, Matsuzawa T, Chaki O, Onoe Y, Aoyagi M, Sasaki T, Tamura T, Koishihara Y, Ohsugi Y, Suda T 1995 Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6. J Bone Miner Res 10:1365-1373.
19. Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones SJ, Boyde A, Suda T 1988 Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122:1373-1382.1
20. Takai H, Kanematsu M, Yano K, Tsuda E, Higashio K, Ikeda K, Watanabe K, Yamada Y 1998 Transforming growth factor-β stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. J Biol Chem 273:27091-27096.
21. 4 subtype regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proc Natl Acad Sci U S A 93:10978-10983.
22. Smithson G, Medina K, Ponting I, Kincade PW 1995 Estrogen suppresses stromal cell-dependent lymphopoiesis in culture. J Immunol 155:3409-3417.
23. Raisz LG 1995 Physiologic and pathologic roles of prostaglandins and other eicosanoids in bone metabolism. J Nutr 125: 2024S-2027S.
24. Lane N, Coble T, Kimmel DB 1990 Effect of naproxen on cancellous bone in ovariectomized rats. J Bone Miner Res 5:1029-1035.
25. Bauer DC, Orwoll ES, Fox KM, Vogt TM, Lane NE, Hochberg MC, Stone K, Nevitt MC 1996 Aspirin and NSAID use in older women: Effect on bone mineral density and fracture risk. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 11:29-35.
26. Morton DJ, Barrett-Connor EL, Schneider DL 1998 Nonsteroidal anti-inflammatory drugs and bone mineral density in older women: The Rancho Bernardo study. J Bone Miner Res 13:1924-1931.
27. Norwood NJ, Elliott J, Martin TJ, Gillespie MT 1998 Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 139:4743-4746.
28. Kizaki M, Norman AW, Bishop JE, Lin C-W, Karmakar A, Koefflet HP 1991 1,25-Dihydroxyvitamin D3 receptor RNA: Expression in hematopoietic cells. Blood 77:1238-1247.
29. Morgan JW, Morgan DM, Lasky SR, Ford D, Kouttab N, Maizel AL 1996 Requirements for induction of vitamin D-mediated gene regulation in normal human B lymphocytes. J Immunol 157:2900-2908.
30. Kurachi T, Morita I, Murota S 1993 Involvement of adhesion molecules LFA-1 and ICAM-1 in osteoclast development. Biochim Biophys Acta 1178:259-266.
31. Miyake K, Medina K, Ishihara K, Kimoto M, Auerbach R, Kincade PW 1991 A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture. J Cell Biol 114:557-565.
32. Springer TA 1994 Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm Cell 76: 301-314.
33. Butcher EC, Picker LJ 1996 Lymphocyte homing and homeostasis. Science 272:60-66.